Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C

doi:10.3748/wjg.v16.i21.2638

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10043)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

601

HTML

9022

Figures (1-3)

218

Tables (1-5)

202

Sum=10043

Jun 7, 2010 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jun 7, 2010; 16(21): 2638-2647
Published online Jun 7, 2010. doi: 10.3748/wjg.v16.i21.2638

Full Size Figure Download Figure

Figure 2 Change in mean serum malondialdehyde (MDA) (A) and serum 4-hydroxyalkenals (B) levels during the treatment period. Error bars indicate SE. P value for the comparison of the Viusid and the control group at 24 wk. A comparative analysis was performed using Wilcoxon rank-sum test.

Citation: Gomez EV, Perez YM, Sanchez HV, Forment GR, Soler EA, Bertot LC, Garcia AY, del Rosario Abreu Vazquez M, Fabian LG. Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C. World J Gastroenterol 2010; 16(21): 2638-2647
URL: https://www.wjgnet.com/1007-9327/full/v16/i21/2638.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i21.2638